药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Econazole
Tariquidar
The serum concentration of Trastuzumab emtansine can be increased when it is combined with Tariquidar.
Econazole
Zosuquidar
The serum concentration of Trastuzumab emtansine can be increased when it is combined with Zosuquidar.
Econazole
Palbociclib
The serum concentration of Palbociclib can be increased when it is combined with Trastuzumab emtansine.
Econazole
Ponatinib
The serum concentration of Ponatinib can be increased when it is combined with Trastuzumab emtansine.
Econazole
Carfilzomib
The serum concentration of Carfilzomib can be increased when it is combined with Trastuzumab emtansine.
Econazole
Etravirine
The serum concentration of Trastuzumab emtansine can be decreased when it is combined with Etravirine.
Econazole
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be decreased when combined with Trastuzumab emtansine.
Econazole
Aripiprazole
The metabolism of Aripiprazole can be decreased when combined with Trastuzumab emtansine.
Econazole
Odesivimab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Odesivimab.
Econazole
Maftivimab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Maftivimab.
Econazole
Atoltivimab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Atoltivimab.
Econazole
Trastuzumab deruxtecan
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Trastuzumab deruxtecan.
Econazole
Zenocutuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Zenocutuzumab.
Econazole
Polatuzumab vedotin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Polatuzumab vedotin.
Econazole
Ustekinumab
The risk or severity of adverse effects can be increased when Ustekinumab is combined with Trastuzumab emtansine.
Econazole
Tildrakizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Tildrakizumab.
Econazole
Naratuximab emtansine
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Naratuximab emtansine.
Econazole
Lorukafusp alfa
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lorukafusp alfa.
Econazole
Lulizumab pegol
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lulizumab pegol.
Econazole
Pinatuzumab vedotin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Pinatuzumab vedotin.